Related references
Note: Only part of the references are listed.EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant
Vanessa P. M. van Empel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure
Ralph J. van Oort et al.
CIRCULATION (2006)
Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction
Cinzia Perrino et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
M Asagiri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy
M Buitrago et al.
NATURE MEDICINE (2005)
MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction
E van Rooij et al.
CIRCULATION RESEARCH (2004)
Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy
BJ Wilkins et al.
CIRCULATION RESEARCH (2004)
Nuclear factor of activated T cells balances angiogenesis activation and inhibition
TA Zaichuk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Sizing up the heart: development redux in disease
EN Olson et al.
GENES & DEVELOPMENT (2003)
NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro
WT Pu et al.
CIRCULATION RESEARCH (2003)
Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy
E van Rooij et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Lifetime risk for developing congestive heart failure - The Framingham Heart Study
DM Lloyd-Jones et al.
CIRCULATION (2002)
Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth
BJ Wilkins et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents
BD Lowes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Impaired cardiac hypertrophic response in calcineurin Aβ-deficient mice
OF Bueno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy - Preservation of systolic function
JA Hill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
CL Antos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress
G Esposito et al.
CIRCULATION (2002)
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
J Mathew et al.
CIRCULATION (2001)
Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy
YZ Zou et al.
CIRCULATION (2001)
Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
LJ De Windt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
BA Rothermel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo - An apoptosis-independent model of dilated heart failure
LJ De Windt et al.
CIRCULATION RESEARCH (2000)
The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis
AM Ranger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
